Twist Bioscience (TWST) Restructuring Costs (2019 - 2026)

Twist Bioscience (TWST) reported Restructuring Costs of $7.2 million for Q1 2026, down 67.98% quarter-over-quarter from $22.5 million in Q4 2019.

Twist Bioscience (TWST) Restructuring Costs (2019 - 2026) Analysis & Trends

Twist Bioscience (TWST) has 2 years of Restructuring Costs data on file, last reported at $7.2 million in Q1 2026.

  • Restructuring Costs for Q1 2026 came in at $7.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $7.2 million (changed N/A YoY), and the FY2020 annual result was $22.5 million, changed N/A from the prior year.
  • Restructuring Costs declined to $7.2 million in Q1 2026 per TWST's latest filing, from $22.5 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $7.2 million in Q1 2026 and troughed at $7.2 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 29,902.70 Bn 29,902.24 Bn 1.11 Bn
2 Thermo Fisher Scientific 175.99 Bn 172.74 Bn 7.74 Bn
3 Danaher 129.87 Bn 124.18 Bn 3.59 Bn
4 Idexx Laboratories 44.75 Bn 44.55 Bn 722.74 Mn
5 Agilent Technologies 37.52 Bn 35.72 Bn 990.00 Mn
6 Iqvia Holdings 30.91 Bn 28.94 Bn 1.36 Bn
7 Natera 30.21 Bn 29.11 Bn 696.04 Mn
8 Illumina 24.19 Bn 23.04 Bn 721.00 Mn
9 Mettler Toledo International 23.12 Bn 23.06 Bn 555.82 Mn
10 Twist Bioscience 4.30 Bn 4.30 Bn 57.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.21 Mn
Dec 31, 2019 22.50 Mn